1. Home
  2. ICUI vs WSFS Comparison

ICUI vs WSFS Comparison

Compare ICUI & WSFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • WSFS
  • Stock Information
  • Founded
  • ICUI 1984
  • WSFS 1980
  • Country
  • ICUI United States
  • WSFS United States
  • Employees
  • ICUI N/A
  • WSFS N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • WSFS Major Banks
  • Sector
  • ICUI Health Care
  • WSFS Finance
  • Exchange
  • ICUI Nasdaq
  • WSFS Nasdaq
  • Market Cap
  • ICUI 3.0B
  • WSFS 3.0B
  • IPO Year
  • ICUI 1992
  • WSFS N/A
  • Fundamental
  • Price
  • ICUI $129.10
  • WSFS $54.68
  • Analyst Decision
  • ICUI Buy
  • WSFS Buy
  • Analyst Count
  • ICUI 6
  • WSFS 4
  • Target Price
  • ICUI $186.60
  • WSFS $66.00
  • AVG Volume (30 Days)
  • ICUI 269.3K
  • WSFS 278.4K
  • Earning Date
  • ICUI 11-11-2025
  • WSFS 10-23-2025
  • Dividend Yield
  • ICUI N/A
  • WSFS 1.25%
  • EPS Growth
  • ICUI N/A
  • WSFS 1.01
  • EPS
  • ICUI N/A
  • WSFS 4.56
  • Revenue
  • ICUI $2,372,504,000.00
  • WSFS $996,364,000.00
  • Revenue This Year
  • ICUI N/A
  • WSFS N/A
  • Revenue Next Year
  • ICUI N/A
  • WSFS $0.87
  • P/E Ratio
  • ICUI N/A
  • WSFS $11.92
  • Revenue Growth
  • ICUI 2.96
  • WSFS 3.83
  • 52 Week Low
  • ICUI $107.00
  • WSFS $42.44
  • 52 Week High
  • ICUI $196.26
  • WSFS $62.75
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 51.94
  • WSFS 39.44
  • Support Level
  • ICUI $121.61
  • WSFS $53.84
  • Resistance Level
  • ICUI $136.61
  • WSFS $59.13
  • Average True Range (ATR)
  • ICUI 4.03
  • WSFS 1.20
  • MACD
  • ICUI 0.24
  • WSFS -0.42
  • Stochastic Oscillator
  • ICUI 49.93
  • WSFS 15.41

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About WSFS WSFS Financial Corporation

WSFS Financial Corp is a savings and loan holding company. The company operates in three segments: WSFS Bank provides loans and leases and other financial products to commercial and consumer customers. Cash Connect segment provides ATM vault cash, smart safe, and other cash logistics services; and Wealth Management provides a broad array of planning and advisor services, investment management, personal and institutional trust services, and credit and deposit products to individuals, corporate, and institutional clients. Majority revenue is generated from WSFS Bank segment.

Share on Social Networks: